New combo therapy aims to tame artery inflammation
NCT ID NCT02902731
First seen Apr 02, 2026 · Last updated Jun 18, 2026 · Updated 12 times
Summary
This study tested whether adding the drug anakinra to standard steroid treatment could lower relapse rates in people with giant cell arteritis, a condition that causes inflamed arteries. The trial planned to enroll 70 adults aged 50 and older but was terminated early with only 30 participants. Researchers compared daily anakinra injections plus steroids against placebo plus steroids over 16 weeks, tracking relapses and steroid use.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GIANT CELL ARTERITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Pr Aouba
Caen, 14000, France
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.